Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shimada

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2025
Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosisSou Otsuki, Masahiro Hatakeyama, Atsushi Michael Kimura, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2019
Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography featuresAya Ikeda, Hitoshi Shimada, Kenya Nishioka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2018
Dual tracer tau PET imaging reveals different molecular targets for <sup>11</sup>C-THK5351 and <sup>11</sup>C-PBB3 in the Alzheimer brainKonstantinos Chiotis, Per Stenkrona, Ove Almkvist, et al.
Parkinsonism & Related Disorders|May 11, 2010
In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI studyMichie Miyoshi, Hitoshi Shinotoh, Zbigniew K Wszolek, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2020
The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's DiseaseHong Tai, Shigeki Hirano, Toru Sakurai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 10, 2018
Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's diseaseSoichiro Kitamura, Hitoshi Shimada, Fumitoshi Niwa, et al.
Annals of Neurology|November 27, 2014
Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathyKazumoto Shibuya, Atsuhiko Sugiyama, Sho-ichi Ito, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3Yasuyuki Kimura, Masanori Ichise, Hiroshi Ito, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 12, 2017
A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the diseaseKeiichiro Tsunoda, Toru Yamashita, Hitoshi Shimada, et al.
Psychopharmacology|January 13, 2012
Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457Keisuke Takahata, Hiroshi Ito, Harumasa Takano, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2025
Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosisSou Otsuki, Masahiro Hatakeyama, Atsushi Michael Kimura, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2019
Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography featuresAya Ikeda, Hitoshi Shimada, Kenya Nishioka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2018
Dual tracer tau PET imaging reveals different molecular targets for <sup>11</sup>C-THK5351 and <sup>11</sup>C-PBB3 in the Alzheimer brainKonstantinos Chiotis, Per Stenkrona, Ove Almkvist, et al.
Parkinsonism & Related Disorders|May 11, 2010
In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI studyMichie Miyoshi, Hitoshi Shinotoh, Zbigniew K Wszolek, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2020
The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's DiseaseHong Tai, Shigeki Hirano, Toru Sakurai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 10, 2018
Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's diseaseSoichiro Kitamura, Hitoshi Shimada, Fumitoshi Niwa, et al.
Annals of Neurology|November 27, 2014
Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathyKazumoto Shibuya, Atsuhiko Sugiyama, Sho-ichi Ito, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2015
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3Yasuyuki Kimura, Masanori Ichise, Hiroshi Ito, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 12, 2017
A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the diseaseKeiichiro Tsunoda, Toru Yamashita, Hitoshi Shimada, et al.
Psychopharmacology|January 13, 2012
Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457Keisuke Takahata, Hiroshi Ito, Harumasa Takano, et al.
Pageof 10